162
Anavex Life Sciences Corp.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
153
FY23:
154
FY24:
136
FY25:
104
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
162
FY22:
153
FY23:
154
FY24:
136
FY25:
104
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.8
FY22:
10.2
FY23:
12.5
FY24:
15.3
FY25:
8.95
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
151
FY22:
142
FY23:
142
FY24:
120
FY25:
94.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
162
FY22:
153
FY23:
154
FY24:
136
FY25:
104
All amounts in millions USD